Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?

Growth Regulation

Volumn 6, Issue 3, 1996, Pages 137-143

  Lindgren, B F ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

End stage renal disease; Hemodialysis; Insulin; Insulin like growth factor binding proteins; Insulin like growth factors

Indexed keywords

GLUCOSE; INSULIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; FEMALE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HUMAN; IMMUNOBLOTTING; INSULIN RESISTANCE; KIDNEY FAILURE; MALE; PROTEIN BINDING; PROTEIN DETERMINATION; RADIOIMMUNOASSAY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL AVAILABILITY; BLOOD GLUCOSE; BLOTTING, WESTERN; CIRCADIAN RHYTHM; FEMALE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; RENAL DIALYSIS; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN;

EID: 0029808836     PISSN: 0956523X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Borah M F, Schoenfeld P Y, Gotch E A, Sargent J A, Wolfson M, Humphreys M H. Nitrogen balance during intermittent dialysis therapy of uremia. Kidney Int 1978; 14: 491-500.
2. Gutierrez A, Alvestrand A, Wahren J, Bergstrom J. Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 1990; 38: 487-494.
3. Zumkeller W, Schofield P N. The role of insulin-like growth factors and IGF-binding proteins in the physiological and pathological processes of the kidney. Virchows Arch B Cell Pathol 1992; 62: 207-220.
4. Baxter R C. Circulating binding proteins for the insulin-like growth factors. TEM 1993; 4: 91-96.
5. Lee P D, Conover C A, Powell D R. Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exp Biol Med 1993; 204: 4-29.
6. Blum W F, Horn N, Kratzsch J, et al. Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regulation 1993; 3: 100-104.
7. Povoa G, Roovete A, Hall K. Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedinbinding protein isolated from human amniotic fluid. Acta Endocrinol (Copenh) 1984; 107: 563-570.
8. Bang P, Eriksson U, Sara V, Wivall I L, Hall K. Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol (Copenh) 1991; 124: 620-629.
9. Bang P. Thesis. Karolinska Institute, 1994.
10. Grill V, Pigon J, Hartling S G, Binder C, Efendic s, Effects of dexamethasone on glucose-induced insulin and proinsulin release in low and high insulin responders. Metabolism 1990; 39: 251-258.
11. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 1986; 154: 138-143.
12. Hilding A, Brismar K, Degerblad M, Thorén M, Hall K. Altered relation between circulating levels of insulin-like growth factor binding protein-1 and insulin in growth hormone deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. J Clin Endocrinol Metab 1995; 80: 2646-2652.
13. Cox G N, McDermott M J, Merkel E, et al. Recombinant insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats. Endocrinology 1994; 135: 1913-1920.
14. Powell D R, Rosenfeld R G, Baker B K, Liu F, Hintz R L. Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acidchromatographed urémie serum. J Clin Endocrinol Metab 1986; 63: 1186-1192.
15. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulinlike growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 1994; 79(3): 872-878.
16. Ericsson F, Lindgren B, Friis K. IGF-I, a marker of catabolism in haemodialysis patients. Abstract 30th Annual Congress European Dialysis and Transplant Association [EDTA], Nephrol Dialysis Transplant 1993; 8: 987.
17. Zapf J, Schmid C, Guler H P, et al. Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF-1 treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia. J Clin Invest 1990; 86: 952-61IS.
18. Powell D R, Liu F L, Baker B, Lee P D K, Belsha C W, Brewer E D, Hintz R L. Characterization of Insulin-like growth factor binding protein-3 in chronic renal failure serum. Pediatr Res 1993; 33: 136-143.
19. Hardouin S, Hossenlopp P, Segovia B, Seurin D, Portolan G, Lassarre C, Binoux M. Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. 1. Circulating forms in man. Eur J Biochem 1987; 170: 121-132.
20. Lewitt M S, Saunders H, Baxter R C. Regulation of rat insulin-like growth factor-binding protein-1: the effect of insulin-induced hypoglycemia. Endocrinology 1992; 131: 2357-2364.
21. Odar-Cederlöf I, Theodorsson E, Eriksson C G, Hamberger B, Tidgren B, Kjellstrand C M. Vasoactive agents and blood pressure regulation in sequential ultrafiltration and hemodialysis. Int J Artificial Organs 1993; 16: 662-669.
22. Bergström J. Cathecolamines and control of blood pressure in hemodialysis and hemofiltration. Kidney Int 1988; 34 (suppl 25): S110-S114.
23. Bellomo R, Colman P G, Caudwell J, Boyce N. Acute continuous hemofiltration with dialysis: effect on insulin concentrations and glycémie control in critically ill patients. Crit Care Med 1992; 20: 1672-1676.
24. Kopple J D. The rationale for the use of growth hormone or insulin-like growth factor I in adult patients with renal failure. Miner Electrolyte Metab 1992; 18: 269-275.
25. Hilding A, Brismar K, Thorén M, Hall K. Glucagon stimulates IGFBP-1 in healthy subjects, patients with pituitary insufficiency and patients with insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1993; 77: 1142-1147.
26. Orskov C, Andreasen J, Hoist J J. All products of proglucagon are elevated in plasma from urémie patients. J Clin Endocrinol Metab 1992; 74: 379-384.